CDCA7–CD44 target pair drives precision elimination of drug-tolerant persister cells in breast cancer
Acta Pharmaceutica Sinica B · 2026-05
DOI: 10.1016/j.apsb.2026.05.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-05. Verfasst von Jin Wu und 12 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Army Medical University, National Natural Science Foundation of China, Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Army Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Wu, J., Tang, Z., Liu, J., Liao, B., Liu, W., Ma, Z., Ma, Q., Zhou, Y., Kong, W., Chen, Q., Zhong, L., Li, C., & Tang, P. (2026). CDCA7–CD44 target pair drives precision elimination of drug-tolerant persister cells in breast cancer. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.05.015
Vancouver
Wu J, Tang Z, Liu J, Liao B, Liu W, Ma Z, et al. CDCA7–CD44 target pair drives precision elimination of drug-tolerant persister cells in breast cancer. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.05.015
BibTeX
@article{Wu2026,
author = {Wu, Jin and Tang, Zhongjie and Liu, Juan and Liao, Bin and Liu, Wei and Ma, Zhongyi and Ma, Qinghua and Zhou, Yuanze and Kong, Weikai and Chen, Qingqiu and Zhong, Ling and Li, Chong and Tang, Peng},
title = {CDCA7–CD44 target pair drives precision elimination of drug-tolerant persister cells in breast cancer},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.05.015}
}
EUVIMED